Dr. Lea Katharina Bühler
About Dr. Lea Katharina Bühler
Dr. Lea Katharina Bühler is the Brand Manager for Multiple Sclerosis at Bristol Myers Squibb in Munich, Germany, with extensive experience in marketing, sales, and diabetes research.
Title
Dr. Lea Katharina Bühler is currently working as the Brand Manager for Multiple Sclerosis at Bristol Myers Squibb in Munich, Bavaria, Germany.
Education and Expertise
Dr. Lea Katharina Bühler holds a PhD in Diabetes Research from Technical University Munich, completed between 2016 and 2020. She earned a Master of Science in Oncology and Cancer Biology from Heidelberg University (2013-2016) and a Bachelor of Science in Molecular Medicine from The University of Freiburg (2010-2013). She also completed a certification course in pharmaceutical marketing strategies in 2021.
Professional Background
Dr. Bühler has amassed extensive experience in the pharmaceutical and research sectors. She started her career as a Student Assistant at The University of Freiburg in 2012 and later undertook a Bachelor Thesis Project in 2013. Additional roles include an Internship Project at the University of Leeds in 2014, an Industrial Trainee position at Novartis in Basel in 2015, and a Master Thesis Project at DKFZ German Cancer Research Center (2015-2016). She also served as a PhD researcher and later as a Member of the Management Board at Helmholtz Zentrum München (2016-2020). At Bristol Myers Squibb, she held various trainee positions before becoming Brand Manager.
Research and Publications
Dr. Bühler authored a research paper on diabetes, published in a peer-reviewed journal during her PhD at Helmholtz Zentrum München. She presented her findings at the European Association for the Study of Diabetes (EASD) conference in 2019. Additionally, she led a collaborative research project between Helmholtz Zentrum München and a pharmaceutical company.
Achievements
Dr. Bühler received a scholarship from the German Academic Exchange Service (DAAD) for her Master's studies at Heidelberg University. She contributed to a multi-center clinical trial on multiple sclerosis treatment options during her tenure at Bristol Myers Squibb. Furthermore, she volunteered as a mentor for undergraduate students in the Molecular Medicine program at The University of Freiburg and participated in a summer school program focused on advanced oncology research techniques at Heidelberg University.